Preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Long-term results

Hip Int. 2012 Jul-Aug:22 Suppl 8:S46-53. doi: 10.5301/HIP.2012.9570.

Abstract

Two-stage revision is the most widely accepted and performed intervention for chronically infected hip prosthesis and different interim spacers have been proposed. In recent years, antibiotic-loaded preformed spacers have become available on the market. The aim of this retrospective study was to assess the long-term results of two-stage revision with preformed spacers and uncemented hip prosthesis for the treatment of septic hip prosthesis. From 2000 to 2010, 183 consecutive patients underwent two-stage revision of septic hip prosthesis, with a same protocol, including preformed antibiotic-loaded cement spacer and a cementless modular hip revision prosthesis and four to six weeks antibiotic administration. Clinical and radiologic assessment at a minimum follow-up of two years was performed. At a minimum two years follow-up, 10 patients (5.4%) had had an infection recurrence, four (2.2%) an aseptic loosening and four more required partial revision of the modular components of the prosthesis, because of hip instability/dislocation; 21 patients died or were lost to follow-up. Considering all the reasons for revision, survivorship at eleven years was 93.9%. Harris Hip Score improved from 29.1 ± 14.6 pre-operatively to 41.1 ± 15.9 after spacer implant and 81.7 ± 17.6 after hip revision. The main complications after spacer implant included: spacer dislocation (16.4%), intra-operative femoral fractures (2.7%), and thromboembolism (2.1%). Complications after hip revision were: instability/dislocation (4,3%), intra-operative femoral fractures (1.6%), and thromboembolism (3.3%). Two-stage revision of septic hip prosthesis with preformed antibiotic-loaded spacers and cementless hip prosthesis provides satisfactory long-term results, with reduced complications.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Antibiotic Prophylaxis*
  • Arthroplasty, Replacement, Hip / adverse effects
  • Arthroplasty, Replacement, Hip / instrumentation*
  • Arthroplasty, Replacement, Hip / methods
  • Bone Cements / therapeutic use*
  • Combined Modality Therapy
  • Female
  • Health Status
  • Hip Joint / microbiology
  • Hip Joint / physiopathology
  • Hip Joint / surgery*
  • Hip Prosthesis*
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prosthesis Design
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / therapy*
  • Quality of Life
  • Range of Motion, Articular
  • Recovery of Function
  • Reoperation
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Bone Cements